Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients
Autor: | N. V. Vorobyev, S. V. Popov |
---|---|
Jazyk: | ruština |
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | Медицинский совет, Vol 0, Iss 19, Pp 106-112 (2018) |
Druh dokumentu: | article |
ISSN: | 2079-701X 2658-5790 |
DOI: | 10.21518/2079-701X-2018-19-106-112 |
Popis: | Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect. The article presents a review of the clinical studies of efficacy and safety, and the experience in using of modern low-molecular-weight heparins in clinical practice - drugs of choice for the prevention of venous thromboembolic complications in cancer patients. Particular attention is paid to Bemiparin - a new second-generation low-molecular-weight heparin with a significant antithrombotic effect and improved pharmacological parameters that allow it to be successfully used in patients with impaired renal function in oncourological practice. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |